Impact of Female Pelvic Reconstruction Surgery on Lower Urinary Tract Symptoms, Psychosomatic Distress and Sexual Function

Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04416152
Collaborator
(none)
100
1
43.2
2.3

Study Details

Study Description

Brief Summary

To get the impact of pelvic floor reconstruction surgery on lower urinary tract symptoms, psychological distress and sexual function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pelvic reconstruction surgery

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
Impact of Female Pelvic Reconstruction Surgery on Lower Urinary Tract Symptoms, Psychosomatic Distress and Sexual Function
Actual Study Start Date :
May 26, 2020
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Change of UDI-6 score [10 years]

    Change of UDI-6 score between baseline and after pelvic reconstruction surgery

  2. Change of IIQ-7 score [10 years]

    Change of IIQ-7 score between baseline and after pelvic reconstruction surgery

  3. Change of psychosomatic score [1 year]

    Change of psychosomatic score between baseline and after pelvic reconstruction surgery

  4. Change of OABSS score [1 year]

    Change of OABSS score between baseline and after pelvic reconstruction surgery

  5. Change of FSFI score [1 year]

    Change of FSFI score between baseline and after pelvic reconstruction surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with pelvic organ prolapse, who will undergo pelvic reconstruction surgery

  • Women who had undergone pelvic reconstruction surgeries in our hospital

Exclusion Criteria:
  • Pregnant woman.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Far Eastern Memorial Hospital Banqiao New Taipei Taiwan 22050

Sponsors and Collaborators

  • Far Eastern Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheng-Mou Hsiao, Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04416152
Other Study ID Numbers:
  • 109045-F
First Posted:
Jun 4, 2020
Last Update Posted:
Jun 4, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2020